Curesponse vs Nectin Therapeutics
Curesponse vs Nectin Therapeutics, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Curesponse is on 55/100 and Nectin Therapeutics on 50/100.
Where each one leads
Curesponse
- our overall score: 55/100 against 50/100
- agent readiness: 50/100 against 21/100
- headcount: 14 against 11
- LinkedIn following: 2,570 against 1,591
Nectin Therapeutics
- domain rating: 23/100 against 17/100
- headcount growth: +2.9% against -4.3%
- funding raised: $64.1M against $28.0M
At a glance
| Measure | Curesponse | Nectin Therapeutics |
|---|---|---|
| What it is | Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing. | Biotech company developing next-generation immunotherapy agents to unlock the immune system. |
| Category | Life Sciences, Cancer, Genomics, Genome Sequencing | Life Sciences, Immunotherapy, Immunology, Cancer |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2017 | 2016 |
| Headquarters | Tel Aviv, Israel | Not published |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Curesponse | Nectin Therapeutics |
|---|---|---|
| Employees | 14 | 11 |
| Headcount growthLast 12 months | -4.3% | +2.9% |
| Total funding | $28.0M | $64.1M |
| Latest round | Series B | Series C |
| LinkedIn followers | 2,570 | 1,591 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Curesponse | Nectin Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 55/100 | 50/100 |
| Traction | 49/100 | 50/100 |
| Team | 70/100 | 30/100 |
| Search visibility | 25/100 | 30/100 |
| Quality | 58/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 17/100 | 23/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Curesponse | Nectin Therapeutics |
|---|---|---|
| Hosting | Google Cloud | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Analytics 4, Segment |
Curesponse vs Nectin Therapeutics: common questions
Which is better, Curesponse or Nectin Therapeutics?
On our 0-100 score Curesponse rates higher (55/100 against 50/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do Curesponse and Nectin Therapeutics compare on the numbers?
Curesponse leads on our overall score (55/100 against 50/100), agent readiness (50/100 against 21/100), headcount (14 against 11), LinkedIn following (2,570 against 1,591). Nectin Therapeutics leads on domain rating (23/100 against 17/100), headcount growth (+2.9% against -4.3%), funding raised ($64.1M against $28.0M).
Read the full Curesponse review and pricing or the Nectin Therapeutics review and pricing. You can also browse other Curesponse alternatives we track.